Sponsors

The Royal Physiographic Society, founded in 1772, is one of the country's oldest scientific academies, focusing on natural sciences, medicine and technology. The society's main task is to support scientific research, i.a. a. by actively participating in the organization of scientific symposia. Contributing to this symposium, which is of high scientific relevance, is thus completely in line with the Society's objectives.

Mats Paulsson's foundation for research, innovation and community building was established in 2011 through a private donation from Mats Paulsson, one of the founders of the construction company Peab. This was decisive for the establishment of the Medicon Village research park and the takeover of AstraZeneca's premises in Lund. Medicon Village today offers a unique environment for life science by integrating research, innovation and entrepreneurship. With the foundation as the owner of Medicon Village, surplus from the operation goes back to research and innovation. By supporting the Lund Spring Symposium, the foundation wishes to promote international knowledge exchange between prominent researchers and at the same time position Skåne as a leading life science region.

text

AGB Pharma is a Swedish pharmaceutical company specializing in sleep disorders. Our mission is to promote good sleep health. Founded and situated in Lund with operations in Sweden, Norway, Denmark and United Kingdom we are a highly skilled organization aiming at expanding our business internationally and to raise awareness of sleep disorders and its impact on quality of life. Why Lund Spring Symposium. AGB-Pharma is keen to build collaborations between academia and industry and is proud to support Lund Spring Symposium and contribute to this significant event.

Lund Spring Symposium is an important opportunity to bring together researchers and entrepreneurs to share knowledge and experience with each other, which we are happy to support. The LMK Foundation believes in cross-disciplinary research and its potential to contribute to solving many of today’s and tomorrow’s problems. Therefore, we support many innovative projects that bring together researchers from various academic backgrounds.

Sound Bioventures is a venture capital firm investing in about-to-be clinical and clinical stage private companies in Europe and the USA. We support the development of novel medicines that address significant unmet medical needs. Our head office is in Malmö, Sweden, 10 minutes from Lund, and with such a high quality conferences next door and right on target for what we do we, have chosen to be a sponsor.

The Lund Spring Symposium in May 2023, was a tour the force at the highest level, covering broad range topics from exciting basic biology to therapeutic R&D programs. As a pharmaceutical company placing innovation at focus, Lundbeck finds it essential to engage in the scientific and biopharma infrastructure in the region close to our main R&D site. We are therefore very much looking forward to another exciting symposium, at the wonderful venues at Lund University, another opportunity to build networks and learn from our Life sciences community.

MultiPark (Multidisciplinary research focused on Parkinson's disease) is a strategic research area (SRA) supported by the S wedish Government. Through a comprehensive scientific programme, we aim to unravel bas ic disease mechan isms, improve diagnostic precision, and develop efficient methods of treatment and care for people affected by neurodegenerative diseases. Building on a tradition of excellence in dopamine research at Lund University, the MultiPark programme was initially focused on Parkinson's disease. However, our netv;ork has gradually expanded to incorporate excellent research on Alzhei mer's, Hun ti ngton's, and neurodegenerative conditions after brain trauma and stroke.

One of the goals of MultiPark is to address unmet medical needs and develop improved treatments for patients affected by neurodegenerative disorders. To this end, an excellent programme of translational pharmacology is crucial. Our network is therefore pleased to support the Lund Spring Symposium, which will help raise the profile of pharmacological research at Lund Un iversity whi le stimu lating new collaborat ions between academia and industry.